Homozygous deletions of cyclin-dependent kinase inhibitor genes, p16INK4A and p18, in childhood T cell lineage acute lymphoblastic leukemias

Leukemia

Volumn 10, Issue 2, 1996, Pages 255-260

  Iolascon, A ^a,d   Faienza, M F ^a   Coppola, B ^a   Della Ragione, F ^b   Schettini, F ^a   Biondi, A ^c  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

^d Piazza G Cesare 11 I 70124 B   (Italy)

Author keywords

ALL; Cell cycle; p16; p18; T cell; Tumor suppressor gene

Indexed keywords

CYCLIN DEPENDENT KINASE; PROTEIN SERINE THREONINE KINASE; TRANSFERASE INHIBITOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CELL CYCLE G1 PHASE; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME 9P; CLINICAL ARTICLE; DELETION MUTANT; FEMALE; GENETIC POLYMORPHISM; HOMOZYGOSITY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; T CELL LEUKEMIA; TUMOR SUPPRESSOR GENE;

EID: 0029881994     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Sager R. Tumor suppressor genes: the puzzle and the promise. Science 1989; 246: 1406-1407.
2. Rowley JD. Recurring chromosome abnormalities in leukemia and lymphoma. Semin Hematol 1990; 27: 122.
3. Kowalczyk J, Sandberg AA A possible subgroup of ALL with 9p-. Cancer Genet Cytogenet 1983; 9: 383-385.
4. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Dav RS III, Johnson BE, Skolnick MH. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436-440.
5. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase 4 inhibitor gene in multiple human cancers. Nature 1994; 368: 753-756.
6. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 1994; 371: 257-261.
7. Sherr CJ. Mammalian G1 cyclins. Cell 1993; 73: 1059-1065.
8. Li Y, Nichols MA, Shav JW, Xiong Y. Transcription repression of D-type cyclin-dependent kinase inhibitor p16 by retinoblastoma susceptibility gene product pRb. Cancer Res 1994; 54: 6078-6082
9. INK4, the product of the putative tumor suppressor gene MTS1. Oncogene 1994; 9: 3475-3482.
10. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, Van der Riet P, Blaugrund JE, Sidransky D. Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 1994; 265: 415-417.
11. Spruck CH, Gonzales-Zulueta M, Shibata A, Simoneau AR, Lin MF, Gonzales F, Tasi YC, Jones PA. p16 gene in uncultured tumors. Science 1994; 370; 183-184.
12. Ogawa S, Hirano N, Takahashi T, Hangaishi A, Tanaka K, Kurokawa M, Tanaka T, Mitani K, Yazaki Y, Hirai H. Homozygous loss of cyclin-dependent kinase 4-inhibitor (p16) gene in human leukaemias. Blood 1994; 84: 2431-2435.
13. Iolascon A, Perrotta S, Mastropietro S, Miraglia E, Oliva A, De Angelis F, Russo GL, Della Ragione F. Homozygous deletions of P16 INK4 gene in childhood acute leukaemias. Blood 1994; 84 (Suppl. 1): 1179.
14. INK4B) display frequent homozygous deletions in primary cells from T-but not from B-cell lineage acute lymphoblastic leukaemias. Blood 1994; 84: 4038-4044.
15. Quesnel B, Preudhomme C, Philippe N, Vanrumbeke M, Dervite I, Lai JL, Bauters F, Wattel E, Fenaux P p16 gene nomozygous deletions in acute lymphoblastic leukaemia. Blood 1995; 85: 657-663.
16. Hatta Y, HiramaT, Miller CW, Yamada Y, Tomonaga M, Koeffler KP. Homozygous deletions of p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Blood 1995; 85: 2699-2704.
17. Okuda T, Shurthlett SA, Valentine MB, Raimondi SC, Head DR, Behm F, Curcio-Brint AM, Liu Q, Pui CH, Sherr CJ, Beach D, Look JA Dowing JR. Frequent deletion of p16 INK4/MTS1 and p15 INK4B/MTS2 in pediatric acute lymphoblastic leukemia. Blood 1995 85: 2321-2330.
18. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982; 79: 2031-2305.
19. INK4B MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Develop 1994; 8: 2939-2952.
20. Borkhardt A, Repp R, Harbott J, Keller C, Berner F, Ritterbach J, Lampert F Frequency and DNA sequence of Tal-1 rearrangement in children with T-cell acute lymphoblastic leukemia. Ann Hematol 1992; 64: 305-307.
21. Brown L, Chen JT, Chen Q, Sicilian MJ, Crist W, Buchanan G, Baer R. Site-specific recombination of the tal-1 gene is a common occurrence in human T-cell leukemia. EMBO J 1990; 9: 3343-3351.
22. Van der Does-Van der Berg A, Bartram CR, Basso G, Benoit YCM, Blondi A, Debatin KM, Haas OA, Harbott J, Kamps WA, Koller U, Lampert F, Ludwig WD, Niemeyer CM, Van Wering E. Minimal requirements for the diagnosis, classification and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the 'BMF family' Cooperative Group. Med Pediatr Oncol 1992; 20: 497-502.
23. Williams DL, Harris A, Williams KJ, Brosius ML, Lemonds W. Direct bone marrow chromosome technique for acute lymphoblastic leukemia. Cancer Genet Cytogenet 1989; 13: 239-243.
24. Maniatis T, Fritsch E, Sambrook J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory: Cold Spring Harbor, NY, 1982.
25. Conter V, Arico M, Valsecchi MG, Rizzari C, Testi A, Messina C, Mori PG, Miniero R, Colella R, Basso G, Rondelli R, Pession A, Masera G. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with BFM-based intensive chemotherapy. J Clin Oncol 1995; 13: 2497-2502.
26. Serra A, Gottardi E, Della Ragione F, Saglio G, Iolascon A. Involvement of the cyclin-dependent kinase 4 inhibitor (CDK4I) gene in the pathogenesis of lymphoid blast crisis of chronic myelogeneous leukemia. Br J Haematol 1995; 91: 625-629.
27. Walker DG, Duan W, Popovic EA, Kaye AH, Tomlinson FH, Lavin M. Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytoma. Cancer Res 1995; 55: 20-23.
28. Kwiatkowsi DJ, Diaz MO. Dinucleotide repeat polymorphism at the IFNA locus (9p22). Hum Mol Genet 1992; 1: 658.
29. Wilkie PJ, Krizman DB, Weber JL. Linkage map of human chromosome 9 microsatellite polymorphisms. Genomics 1992; 12: 607-609.
30. Tam SW, Theodoras AM, Shay JW, Draetta C, Pagano M. Differential expression and regulation of cyclin D1 protein in normal and tumoral human cells: association with Cdk4 is required for cyclin D1 function in G1 progression. Oncogene 1994, 9: 2663-2674.
31. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366: 704-707.
32. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994; 266: 1821-1828.
33. Stranks G, Height SE, Mitchell P, Jadayel D, Yuille MAR, De Lord C, Clutterbuck RD, Treleaven JG, Powles RL, Nacheva E, Oscier DG, Karpas A, Lenoir GM, Smith SD, Millar JL, Catovsky D, Dyer MJS Deletions and rearrangement of CDKN2 in lymphoid malignancy Blood 1995; 85: 893-901.
34. INK4 protein is restricted to the subset of lung cancer lines that retains wilde type Rb. Oncogene 1994; 9: 3375-3378.
35. Minder MD, Mak TW The structure of T-cell antigen receptor genes in normal and malignant T-cells. Blood 1986; 68: 327-332